O
Osamu Kamihira
Researcher at Nagoya University
Publications - 61
Citations - 1218
Osamu Kamihira is an academic researcher from Nagoya University. The author has contributed to research in topics: Nephrectomy & Renal cell carcinoma. The author has an hindex of 15, co-authored 60 publications receiving 1138 citations.
Papers
More filters
Journal ArticleDOI
The long-term outcome of laparoscopic radical nephrectomy for small renal cell carcinoma
TL;DR: Laroscopic radical nephrectomy can be an alternative to open neph rectomy in patients with localized small renal cell carcinoma and long-term results suggest that it is feasible to perform open surgery after laparoscopy in these patients.
Journal ArticleDOI
Neural tube defects: prevalence, etiology and prevention.
TL;DR: Primary prevention of neural tube defects by the periconceptional intake of folic acid is a major public health opportunity and has wide implications in reducing the mortality and morbidity of offspring.
Journal ArticleDOI
Ischemic Renal Damage after Nephron-Sparing Surgery in Patients with Normal Contralateral Kidney
Yasuhito Funahashi,Ryohei Hattori,Tokunori Yamamoto,Osamu Kamihira,Katsuhiko Kato,Momokazu Gotoh +5 more
TL;DR: Although total renal function was almost unaffected before and after NSS, a warm ischemic time of > or = 25 min caused irreversible damage distributed diffusely throughout the operated kidney.
Journal ArticleDOI
Long-term outcome of laparoscopic radical nephrectomy for pathologic T1 renal cell carcinoma.
Takashi Saika,Yoshinari Ono,Ryohei Hattori,Momokazu Gotoh,Osamu Kamihira,Yoko Yoshikawa,Yasushi Yoshino,Shinichi Ohshima +7 more
TL;DR: Laroscopic radical nephrectomy is an alternative technique with comparable oncologic results to open neph rectomy in patients with localized pathologic Stage T1 renal cell carcinoma.
Journal ArticleDOI
Laparoscopic nephroureterectomy for transitional cell carcinoma of renal pelvis and ureter: Nagoya experience.
TL;DR: The authors' retroperitoneal laparoscopic nephroureterectomy is less invasive than open surgery and is a safe and effective alternative for transitional cell carcinoma of the renal pelvis and ureter.